finanznachrichten.de
01-Jul-2008
Insightful Corporation (NASDAQ:IFUL), a leading provider of predictive analytics and reporting solutions, announced today the release and immediate availability of version 1.1 of Insightful Clinical Graphics (iCG), a product for defining and repurposing statistical graphics across all functional areas in drug discovery, development and marketing. iCG 1.1 features new graph types and an improved user experience. Pharmaceutical companies currently starting projects with iCG 1.1 include H. Lundbeck A/S in Denmark. ”Many global pharmaceutical companies are looking to integrate graphics into their clinical trials process, making iCG one of our most significant life science solutions to date,“_ said Jeff Coombs, CEO of Insightful. ”With iCG, customers save time and resources, perform better scientific analysis and interpretation,...
[read full story]